International Clinical Trial: A prospective, multicenter, randomized, non-treatment parallel-controlled, evaluator-blinded, superiority clinical trial study to evaluate the efficacy of recombinant type III humanized collagen-sodium hyaluronate lyophilized fiber on improving skin condition and the safety and efficacy of clinical application

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131990) titled 'A prospective, multicenter, randomized, non-treatment parallel-controlled, evaluator-blinded, superiority clinical trial study to evaluate the efficacy of recombinant type III humanized collagen-sodium hyaluronate lyophilized fiber on improving skin condition and the safety and efficacy of clinical application' on Sept. 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Zhejiang Provincial People's Hospital

Condition: None

Intervention: Experimental group :Recombinant type III humanized collagen-sodium hyaluronate lyophilized fiber injection

Recruitment Status: Not Recruiting

P...